Annals of Internal Medicine tip sheet for Jan. 19, 2... (m channel blockers. Patients and physici...)

Annals of Internal Medicine tip sheet for Jan. 19, 2010, issue

Date:1/18/2010

m channel blockers. Patients and physicians should consider these differences when choosing an antihypertensive therapy.

4. Higher Statin Doses Not Always Best at Preventing Coronary Artery Disease

Statins have proven highly effective at lowering cholesterol. Typically, a treat-to-target approach, which means treating to a target cholesterol level, is taken with statin therapy. However, some experts believe that a tailored approach that uses different dosages based on pateints' risk for cardiovascular disease may be a better strategy for reducing the risk of coronary artery disease. Researchers developed a computer simulation to compare two treatment approaches at the population level-- giving fixed doses of statins on the basis of a person's five-year coronary artery disease risk (tailored treatment), or increasing statin doses to achieve particular lipid level targets (treat-to-target). Compared with the intensive treat-to-target approach, the tailored fixed-dose strategy saved more quality-adjusted life-years and treated fewer persons with high-dose statin therapy. Researchers conclude that tying statin treatment individual risk for heart disease and potential benefits may be better than approaches that focus primarily on achieving certain lipid level targets.

'/>"/>

Contact: Angela Collom
acollom@acponline.org
215-351-2653
American College of Physicians
Source:Eurekalert

0

GOOD

Page: 1 2 3
Related biology news :

1. Annals of the ESA selected as one of 100 most influential journals
2. Plants grow bigger and more vigorously through changes in their internal clocks
3. New research seeks to enhance quality and security of wireless telemedicine
4. Penn Veterinary Medicine report new strategy to create genetically-modified animals
5. SNM applauds NAS study showing need to restore federal nuclear medicine research funding
6. Gene-targeting pioneer Mario Capecchi shares 2007 Nobel Prize in Medicine
7. Professor Sir Martin Evans wins Nobel Prize for Medicine
8. 3 Columbia University Medical Center faculty elected to Institute of Medicine
9. In the laboratory, green tea proves a powerful medicine against severe sepsis
10. Telemedicine: Health alert via satellite
11. Study of African traditional medicine will begin world-first clinical trial

Post Your Comments:

(Date:6/19/2013)... at the University of Pittsburgh has developed antibacterial ... that could be potential treatments for drug-resistant bacterial ... new agents are quite small, making them inexpensive ... in the June 2013 issue of the journal ... first of many probable applications will likely be ...

(Date:6/19/2013)... 19, 2013 MedNet Solutions , a ... management systems, is pleased to announce its participation in ... 23-27 in Boston . This represents ... leader in cloud-based eClinical solutions, has exhibited at this ... iMedNet™ EDC , MedNet,s latest, easy-to-use ...

(Date:6/19/2013)... Insulin is the most potent physiological anabolic agent ... and synthesis of lipids, protein and carbohydrates, and ... system. It also plays a major role in ... glucose is metabolized and removed from the blood ... precise molecular mechanisms by which insulin regulates glucose ...

Breaking Biology News(10 mins):HIV-derived antibacterial shows promise against drug-resistant bacteria 2 MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting 2 Breakthrough research of essential molecule reveals important targets in diabetes and obesity 2

[0] HIV-derived antibacterial shows promise against drug-resistant bacteria [0] MedNet Solutions To Spotlight iMedNet EDC At The 49th DIA Annual Meeting [0] Breakthrough research of essential molecule reveals important targets in diabetes and obesity

... is available in Spanish . , While the ... months, their properties have not been scientifically proven yet by ... berries, components are contained in the recommended fruit and vegetable ... placebo effect" on people consuming them. Also, the species Lycium ...

... 23andMe has launched a project funded by the National ... 23andMe,s highly-scalable platform for pharmacogenomics research. The company received ... Reinvestment Act of 2009 for "Web-based Phenotyping for Genome-Wide ... Genome Research Institute. "One of 23andMe,s ...

... area deep in the brain called the perirhinal cortex is ... Davis Center for Mind and Brain have found. The ... hippocampus, in "declarative" or conscious memories, but the new results ... Wei-chun Wang, a graduate student at UC Davis. The ...

Cached Biology News:Goji berries have the same nutrients as fruits and vegetables and a placebo effect 2 23andMe receives NIH funding to evaluate web-based research on the genetics of drug response 2 Where unconscious memories form 2

Goji berries have the same nutrients as fruits and vegetables and a placebo effect 23andMe receives NIH funding to evaluate web-based research on the genetics of drug response Where unconscious memories form

(Date:6/19/2013)... June 20, 2013 New ... technology solutions for pharmaceutical and chemical sectors ... Manufacturing Pte. Ltd. and Siemens Pte. Ltd, have ... A*STAR R&D Consortium Programme - Innovative Processing of ... of Chemical and Engineering Sciences (ICES), the consortium ...

(Date:6/19/2013)... June 19, 2013 Bellevue city ... hall of technology solutions for people with disabilities ... Hyatt Regency Bellevue. , The exhibit hall, ... on Saturday and Sunday, will feature leading manufacturers ... wheelchairs, communication devices, eyegaze technologies, computer applications, and ...

(Date:6/19/2013)... 2013 U.S. Secretary of State John Kerry ... Syngenta scientist Mary-Dell Chilton , Ph.D., was ... Prize. The prize is the foremost international award recognizing ... quality, quantity or availability of food in the world. ... recognized for "revolutionary biotechnology discoveries that unlocked the key ...

(Date:6/19/2013)... 19, 2013 Clinverse, Inc. ... for clinical trials, today announced it will be ... (booth #2000) in Boston, June 24-26, 2013. ... and only fully configurable, cloud-based clinical financial lifecycle ... module within Clinverse’s eClinical Commerce Network, automates site ...

Breaking Biology Technology:Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 2 Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 3 Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences 4 City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall 2 Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2 Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013 2

[0] Pfizer, GSK, and Siemens Form R&D Consortium With A*STAR's Institute of Chemical & Engineering Sciences [0] City of Bellevue, Wash., Welcomes Assistive Technology Exhibit Hall [0] Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate [0] Clinverse, Inc. Exhibiting and Showcasing Its Technology at DIA 2013

... a liquid-crystal display (LCD) often indicate that a device,s ... Zhong Lin Wang at Georgia Tech, the blinking number ... five-year effort to power conventional electronic devices with nanoscale ... an array of tiny nanowires. In this case, ...

... Reportlinker.com announces that a new market research ... The Future of Molecular Diagnostics: ... medicine http://www.reportlinker.com/p0233955/The-Future-of-Molecular-Diagnostics-Innovative-technologies-driving-market-opportunities-in-personalized-medicine.html ... analysis of DNA and RNA at the ...

... 8, 2010 Reportlinker.com announces that a ... its catalogue: Biomarkers in ... activities of leading players ... and biotechnology sectors are currently facing increasing ...

Nanogenerators grow strong enough to power small conventional electronics The Future of Molecular Diagnostics: Innovative Technologies Driving Market Opportunities in Personalized Medicine Biomarkers in Late Stage Clinical Trials: Applications, Opportunities and Activities of Leading Players

... The ISOQUANT(R) Isoaspartate Detection Kit is ... residues in proteins and peptides, which can ... asparagine or rearrangement of aspartic acid residues ... does not depend on the monitoring of ...

Request Info...

Rb anti-Occludin (C-term GST)...

Request Info...

Biology Products:

ISOQUANT Isoaspartate Detection Kit from Promega Non-Rad Detection Kit from BD Biosciences Pharmingen Rabbit Anti-Occludin, C-Terminus Monoclonal Antibody, GST Conjugated, Clone PADZMD.544 from Invitrogen GIBCO Dulbeccos Phosphate-Buffered Saline (D-PBS) (1X); liquid Contains calcium and magnesium from Invitrogen